| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Corvus Pharmaceuticals, Inc.
13G/A
Amendment 10
CRVS · 221015100
|
7.8% |
2/13/2026
Event 12/31/2025
|
|||
| Richard A. Miller | 7.8% | ||||
| Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 | 1.6% | ||||
| Sandra J. Horning | 1.6% | ||||
|
Corvus Pharmaceuticals, Inc.
13G/A
Amendment 9
CRVS · 221015100
|
7.7% |
2/13/2025
Event 12/31/2024
|
|||
| Richard A. Miller | 7.7% | ||||
| Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 | 2.7% | ||||
| Sandra J. Horning | 2.7% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.